Skip to main content
DNA Labs India

GPC3 Gene Simpson-Golabi-Behmel syndrome type 1 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

GPC3 Gene Simpson-Golabi-Behmel syndrome type 1 NGS Genetic Test

Short Name: GPC3 SGBS1 NGS

Also known as: SGBS1 Genetic Test, GPC3 Mutation Analysis, Simpson-Golabi-Behmel Syndrome Type 1 DNA Test, GPC3 NGS, Glypican 3 Gene Test

GPC3 Gene Simpson-Golabi-Behmel syndrome type 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are typically available within 3 to 4 weeks after the sample is received at the laboratory.. Free home collection in 300+ cities across India.

Molecular Genetic TestMale/FemaleAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify disease-causing variants in the GPC3 gene in individuals with clinical features of Simpson-Golabi-Behmel syndrome type 1 and to confirm a suspected diagnosis. It is also useful for carrier detection in at-risk female relatives and for providing recurrence-risk information for family planning.

Test Code
4503
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are typically available within 3 to 4 weeks after the sample is received at the laboratory.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. A genetic counselling session should be done before the test to document clinical history and draw a pedigree chart of family members affected with GPC3-related Simpson-Golabi-Behmel syndrome type 1. Please carry previous genetic test reports and clinical notes, if available.

Method: Peripheral venous blood collection / dried blood spot on FTA card / extracted DNA submission

Step 2

Laboratory Analysis

Blood is collected by a trained phlebotomist. If an FTA blood spot is being used, one drop of blood is placed on the marked circles and allowed to air dry completely before packaging.

Step 3

Report Delivery

You can resume normal activities immediately after collection. The sample is securely transported to the DNA Labs India laboratory for processing and analysis.

Timeline: Reports are typically available within 3 to 4 weeks after the sample is received at the laboratory.

Patient Instructions

1
Before the Test:No fasting is required. A genetic counselling session should be arranged before testing to discuss the hereditary nature, limitations, and possible outcomes of the test.
2
During the Test:The patient will provide a blood sample, a dried blood spot on an FTA card, or extracted DNA. The procedure is quick and typically involves minimal discomfort.
3
After the Test:No special restrictions are needed after sample collection. The sample is processed in the laboratory, and the report is shared once the analysis and clinical interpretation are complete.

About This Test

Who Should Get This Test

The purpose of this test is to identify disease-causing variants in the GPC3 gene in individuals with clinical features of Simpson-Golabi-Behmel syndrome type 1 and to confirm a suspected diagnosis. It is also useful for carrier detection in at-risk female relatives and for providing recurrence-risk information for family planning.

How to Prepare

  • Pre-test genetic counseling: clinical history and pedigree chart of family members affected with GPC3-related SGBS1 should be documented.
  • Use an EDTA tube for venous blood or the provided FTA card for blood spot collection.
  • Label the sample with patient name, ID, date, and time of collection.
  • For FTA cards, let the blood spot dry thoroughly before placing it in the protective pouch.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"If the clinical phenotype is strongly suggestive of an overgrowth syndrome, targeted GPC3 testing is an appropriate first-line molecular test. However, if the GPC3 result is negative, a broader next-generation sequencing-based overgrowth panel should be considered to look for other genetic causes. Referral to a clinical geneticist for pre-test counselling is essential, especially when results may affect reproductive decisions."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs per laboratory protocol; one drop for FTA card
ContainerEDTA vacutainer / sterile tube / FTA card
Collection MethodPeripheral venous blood collection / dried blood spot on FTA card / extracted DNA submission

Sample Stability

Whole blood in EDTA: transport at 2-8°C and reach laboratory within 72 hours.
FTA blood spots: keep dry and stable at room temperature.
Extracted DNA: store frozen at -20°C and ship on dry ice if a distant location is involved.
Sample Rejection Criteria:
  • Clotted or hemolyzed blood sample
  • Unlabelled or mislabelled sample
  • Improperly dried or contaminated FTA card
  • Insufficient DNA quantity or low-quality DNA

Understanding Your Results

Genetic test results should always be interpreted in the context of clinical findings, family history, and pre-test counselling information. A qualified clinical geneticist or referring specialist should explain the result and its implications.
📊

Pathogenic or likely pathogenic variant detected in GPC3

Supports a diagnosis of SGBS1 in males and carrier status in females. Genetic counselling and family testing are recommended.

📊

No pathogenic variant detected

Reduces the likelihood of GPC3-related SGBS1 but does not rule out the condition. Other overgrowth syndromes may need evaluation.

📊

Variant of uncertain significance (VUS)

Not sufficient for a definitive clinical diagnosis. Additional family segregation studies and further evidence may be required.

⚠️ When to Consult a Doctor:

If the test identifies a pathogenic or likely pathogenic variant, or if clinical symptoms remain suggestive of SGBS1 despite a negative result, consult a clinical geneticist or the referring specialist for personalised management and surveillance.

Limitations

  • This test detects sequence variants in the coding and splice-site regions of GPC3; large deletions or duplications may not be identified.
  • Deep intronic variants, regulatory region variants, and some mosaic low-level variants may be missed.
  • A negative result does not exclude SGBS1 if clinical features are strong; other genes should be considered.
  • Interpretation of variants of uncertain significance may require additional family studies.

Risks & Considerations

  • Mild pain, discomfort, or bruising at the blood collection site
  • Rarely, infection or excessive bleeding after venipuncture
  • No direct physical risks from the genetic test itself, but psychological and emotional implications may occur and should be addressed with counselling

Interfering Factors

  • Allogeneic bone marrow transplantation can lead to donor-derived DNA and inaccurate results
  • Recent blood transfusion may cause mixed DNA in some situations
  • Degraded or insufficient DNA can affect sequencing quality
  • Sample contamination during collection or processing may interfere with results

Compare With Similar Tests

TestGPC3 Gene Simpson-Golabi-Behmel syndrome type 1 NGS Genetic Test
ComparisonGPC3 Gene Simpson-Golabi-Behmel syndrome type 1 NGS Genetic Test

Frequently Asked Questions

What is the GPC3 gene test for Simpson-Golabi-Behmel syndrome type 1?
This is a targeted next-generation sequencing test that reads the coding and splice-site regions of the GPC3 gene to detect pathogenic variants associated with Simpson-Golabi-Behmel syndrome type 1.
Who should get this GPC3 NGS test?
Individuals with clinical suspicion of SGBS1 such as overgrowth, organomegaly, dysmorphic features, skeletal anomalies, or hepatoblastoma, and at-risk female relatives for carrier testing.
What is the cost of the test?
The test costs Rs 20000.0. Free home sample collection is available for online bookings across India.
What type of sample is accepted?
Blood, extracted DNA, or one drop of blood on an FTA card is accepted for this test.
Is fasting required before the test?
No, fasting is not required for the GPC3 NGS genetic test.
How long will it take to get reports?
Reports are usually available within 3 to 4 weeks after the sample is received by the laboratory.
What is next-generation sequencing (NGS)?
NGS is a high-throughput DNA sequencing method that can rapidly analyse multiple regions of the genome, including the GPC3 gene, with high accuracy.
Can a negative GPC3 test rule out Simpson-Golabi-Behmel syndrome type 1?
A negative result makes GPC3-related SGBS1 less likely, but it does not completely exclude the condition. Other genetic causes or non-GPC3 associated phenotypes may need to be considered.
What if a variant of uncertain significance is found?
A variant of uncertain significance (VUS) does not provide a clear diagnosis. It may require additional family segregation studies, functional evidence, and clinical correlation by a genetic specialist.
Can carrier females be tested with this test?
Yes, at-risk females can be tested for carrier status. Since SGBS1 is X-linked, female carriers usually do not show full symptoms but can pass the variant to their children.
Why is genetic counselling recommended before testing?
Genetic counselling helps draw a family pedigree, explains inheritance and recurrence risks, discusses test limitations, and obtains informed consent before proceeding with the genetic test.
Will I receive raw data files along with the report?
Yes, DNA Labs India provides the conclusive clinical report along with raw data files, including FASTQ and VCF files, for transparency and further analysis if needed.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.